ArticleScientific reports2017

Discovery of targetable genetic alterations in advanced non-small cell lung cancer using a next-generation sequencing-based circulating tumor DNA assay.

Helei Hou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.